• Benign Prostatic Hyperplasia (BPH)

• Destruction of Stones in Kidney, Bladder and Ureter

• Tissue-protective Therapy of Strictures and Stenosis of Urethra or Ureter

• Vaporization of Urothelial Tumours

• Vaporization of Condylomata

• and many more

Key Advantage: The physician can efficiently and simultaneously, vaporize and coagulate

soft tissue even at high-risk patients.

• Unique Hardware of

DIOLAS LFD 3000

enables excellent vaporization due to

high absorption in

both water and soft

tissue throughout the

whole procedure.

• Patented LFD Mode

provides thin layer of

coagulation zone,

reducing thermal

damage to only 1 mm.

• More Control during

the procedure by

special fiber probes.

• First Medical Laser worldwide with built-in

programmes for the treatment of BPH, Stones, Condylomata and others

integrated in one single device

• Quick and easy selection of all

programmes & parameters using the

integrated Touch Panel, and power level adjustment using the foot switch

• Comfortable dimmable red laser pilot light during the procedure – no need for

expensive special filters for your camera

system

• Flexible usage of Sidefire and Bare Fibers

for a broad range of procedures

• Low noise level and minimal heat

production achieved using an intelligent control system and unique design

features

• Statistical output of all treatment parameters by an external USB stick

• Eye-safe laser light for less potential complications resulting from laser

radiation

• One device for a whole range of

procedures, no repeated learning of different handling or user interfaces

• Shorter treatment time: Efficient vaporization throughout the whole

procedure even at large prostates

• Excellent Coagulation and Haemostasis, much less complications intra- and

postoperatively

• More Control during the procedure due to

even ablation and precise absorption of

the laser energy. Clear sight without special camera filters

• Clearly reduced short and longterm costs.

Both ablation and enucleation / cutting of tissue are enabled. Bare Fibers are

reusable up to 20 times.

• Shorter patient stay in hospital, day

surgery treatment is possible

• Less maintenance costs compared to Green lasers and other systems

• No special requirements - the laser works at 230 V / 110 V, without external cooling

supplies

• Eye-safe laser light, no special camera filters needed

• Minimal swelling, inflammation, bleeding,

pain intra / postoperatively due to tissue-protective LFD Mode

• Ideal even for High-Risk Patients. Clinical trial showed less complications, taking of

blood-thinning drugs can be continued

• Regular urination is possible immediately after treatment

• Shorter convalescence time, shorter stay in hospital

• DIOLAS LFD 3000 combines best

characteristics of all available alternatives

• The laser is certified to IEC 60601-1:2005

(DIN EN 60601-1:2007)

• Product developed and manufactured in

Germany to quality standard EN ISO

13485:2003

• Engineered specifically for Urology and

Urogynaecology, splash-proof and easy to maintain

•

•

•

–

–

–

–

–

–

•

•

•

–

–

–

•

For a thorough analysis of the

penetration depth and the patient

outcome, various steps were undertaken:

I. Treatment of the BPH Patient

II. Extraction of tissue using TURP

III. Analysis of penetration depth by micro-/

macroscopic views, histology, cystoscopy and 3D ultrasound

The stone destruction feature of DIOLAS LFD

3000 was tested under various scenarios

regarding stone consistency, using rigid or flexible endoscopes, etc.

The current efforts of the extended trial is

directed towards the use of DIOLAS LFD

3000 even for further indications and specialties, such as paediatric surgery,

etc.

• DIOLAS LFD 3000 is a unique device which

allows the treatment of a very extended range of indications in Urology and Urogynaecology

• Patient outcome has improved significantly comparing to other current therapies e.g.

GreenLight, TURP, HoLAP, etc.

• The special combination of hardware and treatment mode LFD enables a thin

coagulation zone with minimal negative side-effects at 1 mm of penetration depth

• Further applications of the laser are yet to be

explored

• Device is strongly backed up by convincing

findings from clinical trial